Skip to content

Pacesetter Sys Fast Pass Endocardial Lead 856 INLI

by Pacesetter Systems 510(k)

Active United States

510(k) K853914

Overview

The Pacesetter Sys Fast Pass Endocardial Lead 856 INLI is a Permanent Pacemaker Electrode, designed for endocardial implantation within the heart’s chambers. This device transmits electrical impulses from an implanted pacemaker to the heart muscle, supporting cardiac rhythm regulation in patients requiring pacing therapy.

This lead is supplied sterile and intended for single-use implantation. It is classified as a Class III device under FDA regulation (product code DTB), with an FDA 510(k) clearance (K853914) granted in 1985. The device adheres to MRI safety standards as defined by its regulatory classification and is intended for use in cardiac electrophysiology procedures.

AI-generated from registry data, 18 Sep 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK853914 Date3 Dec 1985ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Other devices from Pacesetter Systems

See all devices from Pacesetter Systems →

Questions

  • Is this lead designed for reuse in multiple patients, or is it intended for single-use only?

    This lead is explicitly supplied sterile and intended for single-use implantation only. The manufacturer’s description and regulatory classification (FDA 510(k)) confirm it is not meant for reuse across patients, aligning with standard practices for endocardial leads to ensure patient safety and sterility.

  • What heart chambers is this lead approved for implantation within?

    The Pacesetter Sys Fast Pass Endocardial Lead 856 INLI is designed specifically for endocardial implantation, meaning it is intended for placement inside the heart’s chambers (e.g., right atrium or ventricle) to deliver pacing impulses. Its classification as a *permanent pacemaker electrode* reflects this purpose in cardiac electrophysiology procedures.

  • How should this lead be stored before use, and what are the key handling considerations?

    Since the lead is sterile upon supply, it should be stored in its original packaging until immediately before use to maintain sterility. The single-use designation implies it must not be opened or handled beyond the manufacturer’s sterile barrier unless under aseptic conditions for implantation. Proper storage also involves protecting it from physical damage or contamination, as outlined for Class III medical devices.

  • Are there multiple sizes or models available for this lead, or is it a single configuration?

    The provided data lists multiple FEI (Facility Establishment Identifier) numbers (e.g., 3002618605, 2183787), which typically correspond to different lot or batch identifiers rather than distinct sizes or models. However, no explicit size variations (e.g., coil length, tip configurations) are detailed in the description. For precise sizing options, consult the manufacturer’s catalog or technical specifications, as these may vary by clinical application.

  • Does this lead have any specific compatibility requirements with MRI machines, or is it safe for patients who may need MRI scans?

    The lead adheres to MRI safety standards as required for its regulatory classification (Class III, product code DTB). However, the exact MRI compatibility (e.g., safe scan parameters or restrictions) is not detailed in the provided data. Clinicians should verify the manufacturer’s MRI safety information or labeling for the specific model before exposing patients to MRI environments, as risks depend on factors like coil design and scan protocols.